US2019117721A1PendingUtilityA1
Health functional food for inhibiting rise of blood glucose containing coffee and tagatose
Est. expiryMay 4, 2036(~9.8 yrs left)· nominal 20-yr term from priority
A61P 3/10A61K 31/7004A23F 5/36A23F 5/40A23F 5/42A61P 3/08A23L 2/60A61K 36/742A61K 36/74A23V 2250/634A61K 31/047A23V 2250/2108A23V 2200/328
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a health functional food for inhibiting a rise of blood glucose containing coffee and tagatose.
Claims
exact text as granted — not AI-modified1 . A health functional food for inhibiting a rise in blood glucose, comprising coffee and tagatose.
2 . The health functional food of claim 1 , wherein the tagatose is included at a dose of 6 g/day to 10 g/day.
3 . The health functional food of claim 1 , wherein the tagatose is included at a tagatose content of 95% by weight or more, based on the weight of dried solids.
4 . The health functional food of claim 1 , wherein the tagatose is in a crystalline form.
5 . The health functional food of claim 1 , wherein the health functional food further comprises a milk protein.
6 . The health functional food of claim 5 , wherein the milk protein is selected from the group consisting of casein, sodium caseinate, a milk protein isolate, and a milk protein concentrate.
7 . The health functional food of claim 5 , wherein the health functional food further comprises starch syrup.
8 . The health functional food of claim 1 , wherein the coffee contains caffeine.
9 . The health functional food of claim 1 , wherein the inhibition of the rise in blood glucose comprises a decrease in a blood glucose level by 3% to 20% within 30 minutes to 45 minutes after the intake of the health functional food relative to a blood glucose level of the control who does not eat the health functional food.
10 . The health functional food of claim 1 , wherein the inhibition of the rise in blood glucose comprises a decrease in an area under the blood glucose response curve (AUC) by 2% to 10% within 0 minutes to 120 minutes after the intake of the health functional food relative to an area under the blood glucose response curve of the control who does not eat the health functional food.
11 . The health functional food of claim 1 , wherein the inhibition of the rise in blood glucose comprises a decrease in a blood glucose level by 3% to 20% within 30 minutes after the intake of the health functional food relative to a blood glucose level of the control who eats sucrose instead of tagatose in the health functional food.
12 . The health functional food of claim 5 , wherein the inhibition of the rise in blood glucose comprises a decrease in a blood glucose level by 3% to 20% within 15 minutes to 30 minutes after the intake of the health functional food relative to a blood glucose level of the control who eats sucrose instead of tagatose in the health functional food.
13 . The health functional food of claim 5 , wherein the inhibition of the rise in blood glucose comprises a decrease in an area under the blood glucose response curve by 2% to 10% within 0 minutes to 90 minutes after the intake of the health functional food relative to an area under the blood glucose response curve of the control who does not eat the health functional food.
14 . The health functional food of claim 1 , wherein the food is a coffee mix.
15 . A method of inhibiting a rise in blood glucose, comprising:
administering the health functional food according to claim 1 to a subject in need thereof.Join the waitlist — get patent alerts
Track US2019117721A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.